Information PortalData Portal

Data Matrix

Tools & Workflows

Documentation

GSK-1904529A (Compound)

Description: A compound in the knowledge graph

Analyze

CFDE DD-Knowledge Graph

The CFDE Data Distillery Knowledge Graph contains entities and relationships across the CFDE. View GSK-1904529A's neighborhood in the knowledge graph.

Knowledge Graph Assertions

	Source	Relation	Target	Evidence
Loading results...

DISPLAY PER PAGE

Report a bug

Data & Metadata

Tools & Use Cases

@CFDE Workbench 2024

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

Data & Metadata

Tools & Use Cases

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

@CFDE Workbench 2024

Knowledge Graph Assertions

	Source	Relation	Target	Evidence
	GSK-1904529A Compound (Entity type)	Negatively regulates Knowledge Graph Relation (Entity type)	LPL Gene (Entity type)	-0.0041663917
	GSK-1904529A Compound (Entity type)	Positively regulates Knowledge Graph Relation (Entity type)	SGK1 Gene (Entity type)	0.0061307983
	GSK-1904529A Compound (Entity type)	In similarity relationship with Knowledge Graph Relation (Entity type)	SID103905568 Compound (Entity type)	0.3355104625225067
	GSK-1904529A Compound (Entity type)	Negatively regulates Knowledge Graph Relation (Entity type)	ODC1 Gene (Entity type)	-0.004407178
	GSK-1904529A Compound (Entity type)	Negatively regulates Knowledge Graph Relation (Entity type)	DSP Gene (Entity type)	-0.0033512914
	SD-6-035-A2 Compound (Entity type)	In similarity relationship with Knowledge Graph Relation (Entity type)	GSK-1904529A Compound (Entity type)	0.2571031153202057
	GSK-1904529A Compound (Entity type)	In similarity relationship with Knowledge Graph Relation (Entity type)	(4-Bromo-2-fluoro-phenyl)-[6-methoxy-7-(piperidin-4-ylmethoxy)-quinazolin-4-yl]-amine Compound (Entity type)	0.3026091456413269
	GSK-1904529A Compound (Entity type)	Negatively regulates Knowledge Graph Relation (Entity type)	AKR1C2 Gene (Entity type)	-0.003856558
	GSK-1904529A Compound (Entity type)	Negatively regulates Knowledge Graph Relation (Entity type)	PER3 Gene (Entity type)	-0.0035910676
	GSK-1904529A Compound (Entity type)	Positively regulates Knowledge Graph Relation (Entity type)	LDB2 Gene (Entity type)	0.004664721

GSK-1904529A
Compound (Entity type)
Negatively regulates
Knowledge Graph Relation (Entity type)
LPL
Gene (Entity type)
-0.0041663917

GSK-1904529A
Compound (Entity type)
Positively regulates
Knowledge Graph Relation (Entity type)
SGK1
Gene (Entity type)
0.0061307983

GSK-1904529A
Compound (Entity type)
In similarity relationship with
Knowledge Graph Relation (Entity type)
SID103905568
Compound (Entity type)
0.3355104625225067

GSK-1904529A
Compound (Entity type)
Negatively regulates
Knowledge Graph Relation (Entity type)
ODC1
Gene (Entity type)
-0.004407178

GSK-1904529A
Compound (Entity type)
Negatively regulates
Knowledge Graph Relation (Entity type)
DSP
Gene (Entity type)
-0.0033512914

SD-6-035-A2
Compound (Entity type)
In similarity relationship with
Knowledge Graph Relation (Entity type)
GSK-1904529A
Compound (Entity type)
0.2571031153202057

GSK-1904529A
Compound (Entity type)
In similarity relationship with
Knowledge Graph Relation (Entity type)
(4-Bromo-2-fluoro-phenyl)-[6-methoxy-7-(piperidin-4-ylmethoxy)-quinazolin-4-yl]-amine
Compound (Entity type)
0.3026091456413269

GSK-1904529A
Compound (Entity type)
Negatively regulates
Knowledge Graph Relation (Entity type)
AKR1C2
Gene (Entity type)
-0.003856558

GSK-1904529A
Compound (Entity type)
Negatively regulates
Knowledge Graph Relation (Entity type)
PER3
Gene (Entity type)
-0.0035910676

GSK-1904529A
Compound (Entity type)
Positively regulates
Knowledge Graph Relation (Entity type)
LDB2
Gene (Entity type)
0.004664721

DISPLAY PER PAGE